A detailed history of Quest Partners LLC transactions in Natera, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,148 shares of NTRA stock, worth $359,274. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,148
Previous 2,985 28.04%
Holding current value
$359,274
Previous $323 Million 15.64%
% of portfolio
0.02%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$97.75 - $129.67 $81,816 - $108,533
-837 Reduced 28.04%
2,148 $273 Million
Q2 2024

Aug 06, 2024

BUY
$85.28 - $112.6 $253,452 - $334,647
2,972 Added 22861.54%
2,985 $323 Million
Q1 2024

May 09, 2024

SELL
$59.21 - $92.9 $14,980 - $23,503
-253 Reduced 95.11%
13 $1.19 Million
Q4 2023

Feb 09, 2024

BUY
$37.55 - $62.64 $9,988 - $16,662
266 New
266 $16.7 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.